2012 ADA Annual Scientific Sessions

2012 ADA Annual Scientific Sessions | Conference Coverage

July 18, 2012

New research was presented at the American Diabetes Association’s 72nd Scientific Sessions from June 8-12, 2012 in Philadelphia. The features below highlight just some of the studies that emerged from the conference

Heart & Cancer Risks With Insulin

The Particulars: Previous research suggests that there may be an association between insulin use and an increased risk of myocardial infarction, stroke, and several types of cancer.…

A Collaborative Approach to Managing Depression & Diabetes | Opinion Article

November 15, 2011

This Physician’s Weekly feature was completed in cooperation with the experts at the American Diabetes Association.

Interpreting Data on Intensive Glucose Control | Feature

October 25, 2010

Data from three influential trials shed light on whether or not patients with type 2 diabetes should receive intensive glucose control to reduce their risk of developing heart disease.

Brain Pacemakers Improve Epilepsy Treatment | Opinion Article

April 12, 2010

According to the Epilepsy Foundation of America, epilepsy is the third leading neurological disorder, affecting more than 3 million Americans, and more than 200,000 new cases are diagnosed each year. The estimated annual cost of epilepsy is $15.5 billion in direct and indirect costs.…

Preventing Occurrence of Microalbuminuria in Type 2 Diabetes | Feature

January 25, 2010

Data presented at Renal Week 2009 demonstrate that an angiotensin receptor blocker—olmesartan—appears to provide vascular protection in patients with type 2 diabetes by controlling blood pressure and delaying the occurrence of microalbuminuria.…

glucose